Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Author:
Jayaswal, A., Levick, C., Collier, J., Tunnicliffe, E. M., Kelly, M. D., Neubauer, S., Barnes, E., & Pavlides, M.
Journal:
Abdominal Radiology
Publication Year:
2020
Volume/Issue:
46(5)
Pages:
1947-1957
Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
Author:
Andrea Dennis, Matt Kelly, Carolina Fernandes, Sofia Mouchti, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Stephen Harrison, Manu Chakravarthy, Rajarshi Banerjee and Arun Sanyal
Journal:
Frontiers in Endocrinology
Publication Year:
2021
Volume/Issue:
11
Pages:
15308
Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort
Author:
Imajo, K., Tetlow, L., Dennis, A., Shumbayawonda, E., Mouchti, S., Kendall, T., Fryer, E., Yamanaka, S., Honda, Y., Kessoku, T., Ogawa, Y., Yoneda, M., Saito, S., Kelly, C., Kelly, M., Banerjee, R., and Nakajima, A.
Journal:
World Journal of Gastroenterology
Publication Year:
2020
Volume/Issue:
27(7)
Pages:
609–623
Multiparametric MRI imaging, autoimmune hepatitis, and prediction of disease activity
Author:
Katherine Arndtz, Elizabeth Shumbayawonda, James Hodson, Peter J Eddowes, Andrea Dennis, Helena Thomaides-Brears, Sofia Mouchti, Matt D Kelly, Rajarshi Banerjee, Stefan Neubauer, Gideon M Hirschfield
Journal:
Hepatology Communications
Publication Year:
2021
Volume/Issue:
Advance online publication
Pages:
1
...
21 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD